ImmunoPrecise Antibodies Ltd.’s €20 Million Acquisition of BioStrand

Lavery Avocats assisted ImmunoPrecise Antibodies Ltd (IPA) on the deal. ImmunoPrecise Antibodies Ltd (NASDAQ: IPA) acquired BioStrand BV, BioKey BV, and BioClue BV (together, “BioStrand”), a group of…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Sonia Carcano

Author: Sonia Carcano

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here